Showing results (481-490 of 585) with videos related to

Sort By:
Pageof 59
Infection and Immunity|October 1, 1992
The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigenB J Luft, S Mudri, W Jiang, et al.
British Journal of Haematology|October 16, 1999
Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemiaM Lindauer, D Domkin, H Döhner, et al.
Klinische Wochenschrift|November 2, 1987
Acute myelofibrosis in megakaryoblastic leukemia with translocation between chromosomes 8 and 14M Winkelmann, C Aul, R E Scharf, et al.
Brain : a Journal of Neurology|June 10, 2011
Oxidative damage in multiple sclerosis lesionsLukas Haider, Marie T Fischer, Josa M Frischer, et al.
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|June 1, 1996
Fragrance contact dermatitis: a worldwide multicenter investigation (Part I)W Larsen, H Nakayama, M Lindberg, et al.
Brain : a Journal of Neurology|February 28, 2012
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injuryMarie T Fischer, Rakhi Sharma, Jamie L Lim, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 16, 2006
Real-time elastography--an advanced method of ultrasound: First results in 108 patients with breast lesionsA Thomas, T Fischer, H Frey, et al.
British Journal of Haematology|December 31, 1997
Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantroneR F Schlenk, H Döhner, M Pförsich, et al.
International Immunology|June 6, 2000
Positive and negative selection of antigen-specific B cells in transgenic mice expressing variant forms of the V(H)1 (T15) heavy chainJ J Kenny, E G Derby, J A Yoder, et al.
Onkologie|December 1, 1990
Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
Pageof 59